Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.

Journal of neurology - 1 May 2016

Nicoletti Alessandra, Mostile Giovanni, Nicoletti Giuseppe, Arabia Gennarina, Iliceto Giovanni, Lamberti Paolo, Marconi Roberto, Morgante Letterio, Barone Paolo, Quattrone Aldo, Zappia Mario

Abstract excerpt

It is unclear whether patients with different clinical phenotypes of Parkinson's disease (PD) differ in their risk of developing levodopa-induced dyskinesia. We evaluated the possible association between clinical phenotypes and risk of levodopa-induced dyskinesia in PD patients using a case-control design. The FRAGAMP study is a large Italian multicenter study. Patients affected by PD diagnosed according to the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Antiparkinson Agents
Share to Dyskinesia, Drug-Induced

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Interviews as Topic

Share to Levodopa

Share to Logistic Models

Share to Multivariate Analysis

Share to Parkinson Disease

Source

Identifiers

PMID: 26964541
DOI: 10.1007/s00415-016-8075-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026. Manifest publication-graph-cohort-2026-09-06.1.

Source receipt: pubmed, retrieved 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Clinical phenotype and risk of levodopa-induced dyskinesia in Parkinson's disease.PMID 26964541Read ↗

Parkinson Disease: The Relationship Between Non-motor Symptoms and Motor Phenotype.Semantic proximity Read ↗

Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson's disease.Semantic proximity Read ↗

Age at onset and Parkinson disease phenotype.Semantic proximity Read ↗

The FRAGAMP study: environmental and genetic factors in Parkinson's disease, methods and clinical features.Semantic proximity Read ↗

Pharmacogenetic profile and the development of the dyskinesia induced by levodopa-therapy in Parkinson's disease patients: a population-based cohort study.Semantic proximity Read ↗

Phenotypic comparison between combined dystonia-parkinsonism and idiopathic adult-onset dystonia.Semantic proximity Read ↗

Motor phenotype of LRRK2 G2019S carriers in early-onset Parkinson disease.Semantic proximity Read ↗

Isolated parkinsonism is an atypical presentation of GRN and C9orf72 gene mutations.Semantic proximity Read ↗

Defining the Parkinson's disease phenotype: initial symptoms and baseline characteristics in a clinical cohort.Semantic proximity Read ↗

Delineating nonmotor symptoms in early Parkinson's disease and first-degree relatives.Semantic proximity Read ↗

Phenotypic Features of Isolated Essential Tremor, Essential Tremor Plus, and Essential Tremor-Parkinson's Disease in a Movement Disorders Clinic.Semantic proximity Read ↗

Long-Term Cognitive Decline Related to the Motor Phenotype in Parkinson's Disease.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.